News

KeyBanc Affirms Sector Weight on LyondellBasell Amid Challenges

KeyBanc Affirms Sector Weight on LyondellBasell Amid Challenges

KeyBanc's Perspective on LyondellBasell

Recently, KeyBanc has reaffirmed its Sector Weight rating on LyondellBasell Industries (NYSE: LYB) shares, maintaining a neutral stance amidst a backdrop of ongoing soft demand. Particularly, the demand for durable goods continues to wane. Despite these challenging market conditions, LyondellBasell’s management remains hopeful that potential interest rate cuts might pave the way for a recovery as early as 2025.

Current Market Conditions

LyondellBasell has yet to provide significant updates on polyethylene (PE) pricing for the fourth quarter, as negotiations for October contracts are still underway. Management is optimistic about achieving part of its proposed price increase of $0.03 per pound. However, KeyBanc projects that a decline of at least $0.03 per pound is more likely. While October observed the highest PE volume of the year, this spike is attributed more to a rebound from a weaker September than a fundamental change in demand.

Challenges in the I&D Segment

KeyBanc analysts noted continuing softness within the intermediates and derivatives (I&D) segment, a situation exacerbated by diminished demand for durables and contracting margins for methyl tert-butyl ether (MTBE). This year, MTBE spreads have been particularly weak. Furthermore, LyondellBasell is undertaking a strategic review in Europe, with a decision anticipated sometime in 2025, although not in the immediate months ahead.

Valuation and Rating Insights

According to KeyBanc's analysis, although LyondellBasell is making appropriate adjustments to align its operational scale with market realities, it may require several years to return to mid-cycle performance levels. The current structural oversupply in the market has led to perceptions that there exist better risk/reward opportunities in other areas of the chemical sector.

Performance Metrics

LyondellBasell's stock trades at a multiple that KeyBanc views as fair, pegged at 4.9 times mid-cycle earnings before interest, taxes, depreciation, and amortization (EBITDA). The reiteration of the Sector Weight rating reflects both this valuation and the broader challenges that the company faces within the industry.

Analysts' Adjusted Outlooks

In recent news, financial analysts have adjusted their outlook for LyondellBasell. Citigroup analyst Pat Cunningham revised the price target down to $92 from $100 while maintaining a neutral position. This adjustment follows findings from LyondellBasell's latest earnings call, revealing a notable decline in EBITDA within the Oxyfuels and Refining segments. Similarly, Jefferies adjusted its price target for LyondellBasell shares to $96 from $101, while keeping a hold rating.

Quarterly Earnings Report

Despite operating in a challenging market, LyondellBasell reported third-quarter earnings per share of $1.88, with an EBITDA of $1.2 billion. The company generated $670 million from operations, with its Olefins and Polyolefins - Americas segment experiencing a sequential EBITDA increase of 13%. Conversely, the refining segment faced a setback, reporting a $23 million EBITDA loss.

Strategic Initiatives and Future Plans

LyondellBasell continues its strategic initiatives, including the construction of the MoReTec-1 recycling facility and plans to shut down its Houston refinery. The company is targeting an unlocking of at least $600 million in annual EBITDA by the end of 2024 and is aiming to reach $1 billion by the end of 2025.

Financial Health and Dividend Considerations

Recent insights reveal LyondellBasell's market capitalization at $27.41 billion, with a P/E ratio of 12.88, suggesting a low valuation relative to earnings. Notably, LyondellBasell offers a dividend yield of 6.19%, which reflects a 7.2% growth over the past year. Such features may attract income-focused investors despite the overarching market challenges.

Frequently Asked Questions

What is KeyBanc's rating on LyondellBasell?

KeyBanc maintains a Sector Weight rating on LyondellBasell shares amid soft demand conditions.

How is LyondellBasell performing financially?

In its third quarter, LyondellBasell reported earnings per share of $1.88 and an EBITDA of $1.2 billion.

What challenges is LyondellBasell facing?

The company is dealing with declining demand for durable goods and weak margins in certain segments.

What is the expected EBITDA growth for LyondellBasell?

LyondellBasell aims to unlock $600 million in annual EBITDA by the end of 2024 and $1 billion by the end of 2025.

How is LyondellBasell's dividend performance?

LyondellBasell offers a dividend yield of 6.19% with a 7.2% dividend growth over the past year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Dorman Products: Anticipating Positive Earnings Ahead

Updated Category News Views 264

Optimistic Earnings Outlook for Dorman Products Dorman Products (NASDAQ: DORM) is gearing up to announce its quarterly earnings report soon, generating buzz among investors. The anticipated release date is approaching, and many are keen to see how the company performs. Expectations Surrounding EPS Analysts have set expectations high, forecasting an earnings per share...

Continue Reading
Fission Uranium Corp. Publishes Results from Special Meeting

Updated Category News Views 53

Fission Uranium Corp. Shares Results from Special Meeting Fission Uranium Corp. (TSX: FCU, OTCQX: FCUUF) recently conducted an important meeting with its securityholders. During this special meeting, the company revealed the results of key votes that will shape its future direction and partnership strategies. Shareholders Express Strong Support for Key Resolutions At the...

Continue Reading
Prevounce Health Enhances Integration with Elation Health's EHR

Updated Category News Views 173

Prevounce Health Partners with Elation Health for Enhanced Care The integration between the Prevounce remote care management platform and the Elation electronic health record (EHR) system marks a significant advancement in healthcare technology. This partnership aims to streamline healthcare processes and enhance patient care through technological synergy. Understanding...

Continue Reading
Exploring the Expanding Landscape of Social Media Listening

Updated Category News Views 196

Growing Demand for Social Media Listening The social media listening market is experiencing remarkable growth, expected to surge from USD 8.36 billion in 2023 to USD 27.63 billion by the year 2032. This projection represents a compound annual growth rate (CAGR) of approximately 14.27% during the forecast period. The increasing need for real-time insights into consumer...

Continue Reading
Orthopedic Braces Market Set to Surge to $5.5 Billion by 2030

Updated Category News Views 123

Overview of the Orthopedic Braces and Supports Market The global orthopedic braces and supports market is currently experiencing significant growth, with a valuation of approximately US$3.8 billion in 2024. This market is expected to reach US$5.5 billion by 2030, showcasing a compound annual growth rate (CAGR) of 6.5% across this period. One of the primary factors...

Continue Reading